Results 361 to 370 of about 1,067,293 (391)
Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade. [PDF]
Neuro OncolHung CY +14 more
europepmc +1 more source
Ex vivo modelling of human colorectal cancer liver metastasis by normothermic machine perfusion. [PDF]
Mol CancerTrebo M +20 more
europepmc +1 more source
Myeloid cell-specific type I interferon signaling mediates age-dependent inflammation and protection in <i>Bordetella pertussis</i> infection. [PDF]
Infect ImmunKumar A, Bukowski A, Carbonetti NH.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Hematology, 2020
Purpose of review Myeloid sarcoma; also known as granulocytic sarcoma and chloroma, often occurs concomitantly with AML, and rarely without bone marrow involvement. In this article, we review the recent literature on myeloid sarcoma, focusing on treatment approach for this rare disease, and addressing the prognostic and ...
Omar A, Shahin, Farhad, Ravandi
openaire +2 more sources
Purpose of review Myeloid sarcoma; also known as granulocytic sarcoma and chloroma, often occurs concomitantly with AML, and rarely without bone marrow involvement. In this article, we review the recent literature on myeloid sarcoma, focusing on treatment approach for this rare disease, and addressing the prognostic and ...
Omar A, Shahin, Farhad, Ravandi
openaire +2 more sources
CD1c(+) myeloid dendritic cells in myeloid neoplasia
Cytometry Part B: Clinical Cytometry, 2015We determined the normal level and phenotype of CD1c(+) myeloid dendritic cells (MDCs) in blood and bone marrow and evaluated the level of CD1c(+) MDCs in 295 myeloid neoplasms. CD1c(+) MDCs were increased above the mean level of non‐neoplastic hospital controls in 18.0% (53/295) of myeloid malignancies, increased three standard deviations above the ...
Alison Edinger +7 more
openaire +3 more sources
Oncology Research and Treatment, 2019
Hematological malignancies can manifest as extramedullary soft tissue masses in relatively rare cases. The rarity of it causes a diagnostic and therapeutic challenge. One of the rarest manifestations is myeloid sarcoma (MS). MS develops as part of acute myeloid leukemia, myeloproliferative neoplasm, or myelodysplastic syndrome or at relapse, especially
Mohamed, Magdy +5 more
openaire +2 more sources
Hematological malignancies can manifest as extramedullary soft tissue masses in relatively rare cases. The rarity of it causes a diagnostic and therapeutic challenge. One of the rarest manifestations is myeloid sarcoma (MS). MS develops as part of acute myeloid leukemia, myeloproliferative neoplasm, or myelodysplastic syndrome or at relapse, especially
Mohamed, Magdy +5 more
openaire +2 more sources
The International Journal of Biochemistry & Cell Biology, 2004
Granulocytes and monocytes, collectively called myeloid cells, are differentiated descendants from common progenitors derived from hematopoietic stem cells in the bone marrow. Commitment to either lineage of myeloid cells is controlled by distinct transcription factors followed by terminal differentiation in response to specific colony-stimulating ...
Hiroshi, Kawamoto, Nagahiro, Minato
openaire +2 more sources
Granulocytes and monocytes, collectively called myeloid cells, are differentiated descendants from common progenitors derived from hematopoietic stem cells in the bone marrow. Commitment to either lineage of myeloid cells is controlled by distinct transcription factors followed by terminal differentiation in response to specific colony-stimulating ...
Hiroshi, Kawamoto, Nagahiro, Minato
openaire +2 more sources